GH Research (GHRS) Assets Average (2021 - 2025)
GH Research (GHRS) recorded quarterly Assets Average of $295.1 million in Q4 2025, down 4.09% quarter-over-quarter from $307.7 million in Q3 2025, and up 52.17% on a YoY basis from $193.9 million in Q4 2024.
GH Research (GHRS) Assets Average (2021 - 2025) Analysis & Trends
GH Research's Assets Average history runs 5 years deep, the most recent figure standing at $295.1 million for Q4 2025.
- In Q4 2025, Assets Average rose 52.17% year-over-year to $295.1 million; the TTM figure through Dec 2025 stood at $295.1 million (up 52.17% YoY), while the FY2025 annual figure was $238.3 million, up 14.94% from the prior year.
- Assets Average was $295.1 million for Q4 2025 at GH Research, down from $307.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $316.9 million in Q2 2025 to a low of $193.9 million in Q4 2024.
- Historically, Assets Average has averaged $254.5 million across 5 years, with a median of $254.4 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Assets Average dropped 15.47% in 2024, then soared 52.17% in 2025.
- A 5-year view of Assets Average shows it stood at $286.9 million in 2021, then slipped by 10.33% to $257.2 million in 2022, then declined by 10.81% to $229.4 million in 2023, then fell by 15.47% to $193.9 million in 2024, then jumped by 52.17% to $295.1 million in 2025.
- The last three Assets Average figures came in at $295.1 million (Q4 2025), $307.7 million (Q3 2025), and $316.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 660.38 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 295.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 295.13 Mn |
| Sep 30, 2025 | 307.73 Mn |
| Jun 30, 2025 | 316.94 Mn |
| Mar 31, 2025 | 254.36 Mn |
| Dec 31, 2024 | 193.94 Mn |
| Sep 30, 2024 | 203.29 Mn |
| Jun 30, 2024 | 212.28 Mn |
| Mar 31, 2024 | 221.94 Mn |
| Dec 31, 2023 | 229.43 Mn |
| Sep 30, 2023 | 236.42 Mn |
| Jun 30, 2023 | 244.77 Mn |
| Mar 31, 2023 | 251.81 Mn |
| Dec 31, 2022 | 257.24 Mn |
| Sep 30, 2022 | 263.22 Mn |
| Jun 30, 2022 | 269.93 Mn |
| Mar 31, 2022 | 280.83 Mn |
| Dec 31, 2021 | 286.87 Mn |